Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2017; 7(11): 119-125


ASSESSMENT OF QUALITY OF LIFE AND SEVERITY OF ITCHING PRE AND POST DOXEPIN THERAPY IN DIALYSIS PATIENTS WITH PRURITUS

Kousalya Prabahar, Danda Anusha, Soundararajan Periasamy, Boddu Sri Venkata Rishitha, Anand Ramanathan, Dasari Anudeep.

Abstract
Objective: Chronic kidney disease (CKD)-associated pruritus is a significant clinical symptom affecting more than 50% of patients on hemodialysis. The main aim of this study was to assess the effects of doxepin treatment on the quality of life of pruritic patients.
Material and methods: This prospective-interventional study was carried out for a period of 6 months in dialysis unit of Department of Nephrology in a tertiary care teaching hospital, Chennai. Both inpatients and outpatients of both sexes ≥ 18 years on hemodialysis or peritoneal dialysis for more than 3 months with pruritus were included for the study. A total number of 39 dialysis patients with pruritus were recruited for the study. Patients were evaluated at the beginning of the study and at the end of 2 weeks of each study period. The severity, duration, degree, direction, disability and distribution of itch were evaluated using 5D- pruritus scale. The quality of life of patients was assessed using DLQI questionnaire (Dermatology Life Quality Index).
Results: There was an improvement in quality of life of patients with pruritus after doxepin therapy.
Conclusion: Doxepin is a better therapy for itching and improving the quality of life in dialysis patients. Clinicians should enquire about skin irritation and itching during consultations since patients may be reluctant to admit to these symptoms due to embarrassment.

Key words: Itch; pruritus; doxepin.



Similar Articles

Prurigo Simplex or "Itchy Red Bump" Disease: Review and Case Series.
Wallengren J
Acta dermato-venereologica. 2021; ():

Effectiveness and safety profiling of zolpidem and acupressure in CKD associated pruritus: An interventional study.
Rehman IU, Ahmed R, Rahman AU, Wu DBC, Munib S, Shah Y, Khan NA, Rehman AU, Lee LH, Chan KG, Khan TM
Medicine. 2021; 100(21): e25995

Rs4911154 of circ-ITCH aggravated tumor malignancy of thyroid nodules via the circ-ITCH/miR-22-3p/CBL axis.
Guo Y, Zheng H, Yin J, Wang H
Scientific reports. 2021; 11(1): 18491

Multiple skin ulceration and itch-scratch cycle in a diabetic patient.
Murao S, Murao K
Journal of diabetes investigation. 2021; ():

IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch.
Abreu M, Miranda M, Castro M, Fernandes I, Cabral R, Santos AH, Fonseca S, Rodrigues J, Leander M, Lau C, Freitas I, Coimbra S, Santos-Silva A, Lima M
Advances in hematology. 2021; 2021(): 5582581


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites